Alexandra P. Song - AbbVie, Inc | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 33 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

P741 Characterisation of Endoscopic Improvements with Risankizumab Treatment in Patients with Moderately to Severely Active Crohn’s Disease

W. Reinisch,J. F. Colombel, C. Ma,M. Long,P. M. Irving, D. O'Brien,K. Kligys,A. Song, Y. Zhang,G. D'Haens

JOURNAL OF CROHNS & COLITIS (2024): I1378-I1379

引用0浏览0引用

Su1761 EFFICACY AND SAFETY UP TO THREE YEARS OF RISANKIZUMAB TREATMENT IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE: RESULTS FROM THE FORTIFY OPEN-LABEL LONG-TERM EXTENSION

Marc Ferrante,Remo Panaccione,Jean Frederic Colombel,Marla C. Dubinsky,Tadakazu Hisamatsu,James O. Lindsay,Alexandra P. Song,Ezequiel Neimark, Ying Zhang,Kristina Kligys, Jameson Crowley,W. Rachel Duan,Geert D'Haens

GASTROENTEROLOGY（2024）

引用0浏览0引用

SERENE ER Analysis Part 1-SERENE CD: Exposure-Response Analysis of Higher Versus Standard Adalimumab Dosing Regimens for Patients with Moderately to Severely Active Crohn Disease

Mong-Jen Chen,Ana Victoria Ponce-Bobadilla,Sven Stodtmann,Alexandra P. Song,Tricia K. Finney-Hayward,Nael M. Mostafa

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENTno. 9 (2024): 1024-1032

引用0浏览0WOS引用

EFFICACY OF RISANKIZUMAB BY BASELINE CLINICAL, BIOCHEMICAL, AND ENDOSCOPIC DISEASE SEVERITY IN MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

Remo Panaccione,Geert D'Haens,John Paul Seenan,Flavio Caprioli,Corey A. Siegel,Masanao Nakamura,Shu Chen Wei,Kristina Kligys,Yafei Zhang,Javier A. Zambrano,Alexandra P. Song,Marc Ferrante

Gastroenterologyno. 6 (2023): S-1098

引用0浏览0引用

P544 Patients with Moderate to Severe Crohn’s Disease with and Without Prior Biologic Failure Demonstrated Improved Clinical Outcomes with Risankizumab: Results from Phase 3 Induction and Maintenance Trials

Geert R. D’Haens,Melanie Beaton,Peter Bossuyt,Iris Dotan,Bruce E. Sands,Ken Sugimoto,Ezequiel Neimark,Alexandra P. Song,Kori Wallace,Qian Zhou,Kristina Kligys,Marc Ferrante

Journal of Crohn s and Colitis（2022）

引用1浏览0引用

Tu1470: RISANKIZUMAB MAINTENANCE THERAPY RESULTS IN SUSTAINED IMPROVEMENTS IN ENDOSCOPIC OUTCOMES IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE: POST-HOC ANALYSIS FROM THE PHASE 3 STUDY FORTIFY

Peter M. Irving,Maria T. Abreu,Jeffrey Axler,Xiang Gao,Joana Torres,Ezequiel Neimark,Alexandra P. Song,Kori Wallace,Kristina Kligys,Sofie Berg,Xiaomei Liao,Remo Panaccione

Gastroenterologyno. 7 (2022): S-975

引用0浏览0引用

DOP84 Risankizumab Maintenance Therapy Results in Sustained Improvements in Endoscopic Outcomes in Patients with Moderate to Severe Crohn’s Disease: Post-hoc Analysis from the Phase 3 Study FORTIFY

Peter M. Irving,Maria T. Abreu,Jeffrey Axler,Xiang Gao,Joana Torres,Ezequiel Neimark,Alexandra P. Song,Kori Wallace,Kristina Kligys,Sofie Berg,Xiaomei Liao,Remo Panaccione

Journal of Crohn's and colitis（2022）

引用2浏览0引用

DOP82 Achievement of Steroid-Free Remission in Patients with Moderately to Severely Active Crohn’s Disease During Treatment with Risankizumab

Stefan Schreiber,Raymond K. Cross,Remo Panaccione,Geert D'Haens,Peter Bossuyt,Jean Frederic Colombel,Edouard Louis,Marla Dubinsky,Kristina Kligys,Ezequiel Neimark,Alexandra P. Song,Javier A. Zambrano,Erica Cheng,Marc Ferrante

Journal of Crohn s and Colitis（2022）

引用1浏览0引用

DOP83 Normalisation of Biomarkers and Improvement in Clinical Outcomes in Patients with Crohn’s Disease Treated with Risankizumab in the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies

R. Atreya,B. Feagan, O. Shchukina,V. Jairath,F. Rieder,T. Hisamatsu,B. Siegmund, J. Rizzo,K. Kligys,E. Neimark,A. Song,J. Zambrano,M. Mallick,E. Cheng,A. Armuzzi

Journal of Crohn s and Colitis（2022）

引用1浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn